Company Overview and News

0
Toro Energy generating gold drilling targets at Yandal project

2018-06-29 proactiveinvestors.com.au
Toro Energy Ltd (ASX:TOE) is generating gold targets for upcoming exploration, including drilling, at the Yandal project within the world-class Yandal Greenstone Belt gold district of Western Australia.
EAR TOE TOEYF

3
Renegade Exploration continues major drill program at Yandal East Gold Project

2018-06-26 proactiveinvestors.com.au
Renegade Exploration Ltd (ASX:RNX) has completed drilling at the Coralie Jean prospect within its Yandal East Gold Project in Western Australia.
EAR BKHRF NSR SCEXF NST BLK NHRNY SAR NESRF

3
Renegade Exploration trades higher as activity heats up in the Yandal Greenstone Belt

2018-06-07 proactiveinvestors.com.au
Renegade Exploration Ltd (ASX:RNX) continues to attract investors as the company's exploration plans in the world-class Yandal Greenstone Belt advance.
EAR DRG BKHRF AYR NSR SCEXF NST BLK NHRNY SAR NESRF

3
Renegade Exploration commencing maiden drill program at Yandal Greenstone Belt

2018-05-29 proactiveinvestors.com.au
Renegade Exploration Ltd (ASX:RNX) non-executive director Mark Wallace speaks to Proactive Investors about the gold exploration and development company’s imminent 20,000 to 25,000 metre aircore program at Yandal East in the world-class Yandal Greenstone Belt.
EAR NST NHRNY NESRF

3
Renegade Exploration revs up for major drilling program in premier gold country

2018-05-21 proactiveinvestors.com.au
Renegade Exploration Ltd (ASX:RNX) will get the drill bit spinning in early June targeting gold at its Yandal East project in the gold-rich Yandal Greenstone Belt of Western Australia.
EAR DRG BKHRF AYR NSR SCEXF NST BLK NHRNY SAR NESRF

3
Renegade Exploration leveraged to gold news flow from world-class Yandal Greenstone Belt

2018-05-10 proactiveinvestors.com.au
Renegade Exploration Ltd (ASX:RNX) is focused on finding another major gold project in the elephant country that is the Yandal Greenstone Belt near Wiluna in Western Australia’s North Eastern Goldfields.
EAR DRG BKHRF AYR NSR SCEXF NST BLK NHRNY SAR NESRF

1
Alloy Resources applies for new ground as it looks to emulate big players like Northern Star

2018-04-17 proactiveinvestors.com.au
Alloy Resources Limited (ASX:AYR) has applied for new ground south of the company’s Horse Well Gold Project joint venture in Western Australia.
EAR AYR NST

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:EAR / ECHO RESOURCES LIMITED on message board site Silicon Investor.

Research Frontiers (REFR) Computer Learning
Heart Attacks, Cancer and strokes. Preventative approaches Rare Earth Elements and Exotic Metals
Chicago Bears Fan Club Anthony @ Equity Investigations, Dear Anthony,
BB: BlackBerry (fka RIMM: Research in Motion) ABMD - Replacement Heart System
The Singularity, A.I.: Machine u0026 Deep Learning,. and GFA Effective Collaboration - Team Research for Better Returns: